ARCHIVES

Gallo To Say, For Now, DeVita Says: Core Grants Face Big Cut

This article is from The Cancer Letter archive.

Vol. 14 No. 12 | March 18, 1988

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG

July 10, 1998

First Compound From New In Vitro Screening to Enter Clinical Trials

December 5, 1986